Amonafide in Combination With Cytarabine in Secondary AML
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Steven Allen, MD
North Shore Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Vancouver General Hospital
Vancouver, British Columbia, Canada
- London Regional Cancer Program, London Health Science Center
London, Ontario, Canada
- University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
- City of Hope National Medical Center
Duarte, California, United States
- Ucla Medical Center
Los Angeles, California, United States
- Scripps Cancer Center
San Diego, California, United States
- University of Colorado Health Sciences Center, Anschutz Cancer Center
Aurora, Colorado, United States
- University of Florida Health Science Center
Gainesville, Florida, United States
- Northwestern University, Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois, United States
- St. Francis Cancer Research Foundation (formerly Indiana Oncology Hematology Consultants and American Health Network of Indiana Llc, Oncology Division)
Indianapolis, Indiana, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Musc - Hollings Cancer Center
Charleston, South Carolina, United States
- Baylor University Medical Center
Dallas, Texas, United States
- West Virginia University Medical Center
Morgantown, West Virginia, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2005
- Primary completion
- —
- Completion
- 30 Apr 2009
- Last update posted
- 19 Feb 2007
- Registered enrollment
- 80
- Registry id
- NCT00273884
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.